Fresenius AG (SE)

Fresenius Medical Care AG & Co. KGaA Announces the Offering of US$ 500 million of 10 Year Senior Notes for Refinancing Purposes

(lifepr) Bad Homburg v.d.H., 18.06.2007, Fresenius Medical Care AG & Co. KGaA (“the Company”) (Frankfurt Stock Exchange: FME, FME3) (NYSE: FMS, FMS-p), the world’s largest provider of Dialysis Products and Services, today announced that it intends to sell approximately US$ 500 million senior unsecured notes. The notes will be offered mainly to US institutional investors. Proceeds from the offering will be used to reduce indebtedness under the Company’s senior secured bank credit facility and other, short-term debt, and for general corporate purposes.

The proposed offering will not be registered under the Securities Act of 1933, but will be offered in the United States pursuant to an exemption from registra-tion under Rule 144A as well as outside the United States under Regulation S. The Company expects completion of the offering at the beginning of July 2007.

Weitere Meldungen dieses Unternehmens

• 14.12.2011 - HELIOS schließt Übernahme des Katholischen Klinikums Duisburg...
• 16.11.2011 - Fresenius plans purchase of Fresenius Medical Care ordinary shares...
• 16.11.2011 - Fresenius plant Zukauf von Fresenius Medical Care-Stammaktien,...
• 08.11.2011 - Weihnachtsspende der Fresenius Kabi Deutschland GmbH
• 02.11.2011 - Fresenius mit Rekordergebnis im 3. Quartal - verbessert Ergebnisausblick
• 31.10.2011 - HELIOS übernimmt Mehrheit am Katholischen Klinikum Duisburg